Home

Home

Spores simply wiped out

Gama Healthcare has developed an advanced innovative wipe — Clinell Sporicidal — which, the company reports, is the world’s first peracetic acid generating wipe specifically designed to deal with spores.

 The wipe was developed by a team of medical doctors and contains patent pending technology designed around the stability of the peracetic acid, the company adds.

‘Clinell Sporicidal offers an easier and much safer option than the chemicals currently recommended to deal with spores such as Chlorine and Glutaraldehyde based compounds. The wipe is activated with the simple addition of water, which produces peracetic acid instantaneously to levels which are proven to kill all known germs. Peracetic acid works extremely well in dirty conditions (unlike Chlorine) and can be used directly on fresh blood spills, which will activate the wipe immediately without the need for water. The fumes produced are non-toxic, which allows for use in close proximity to patients. The breakdown products are environmentally friendly and contain no alcohol or organic solvents.

‘Clinell Sporicidal is the most powerful wipe to ever be created and its development constitutes a major advancement in wipe technology and infection control. In addition, it is set to become the gold standard for dealing with spore outbreaks in hospitals and healthcare institutions across the world.’

This article was published on 11/14/2007

Search

 

Service

Company News

EH 6/08 as E-paper

Our latest issue of EUROPEAN HOSPITAL, EH 6/2008, is once again chock full of great articles, for example a feature on a Czech health spa located in the beautiful Carpathian Mountains and another management special on healthcare for Muslim patients across Europe. But Europe is not enough: you will get a first-hand assessment of RSNA 2008, the Annual Meeting of the Radiological Society of North America, which took place in Chicago, and we are presenting an ambitious project by US oncologists to provide access to advanced diagnostics and radiotherapy treatments in developing countries.